The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
| RUDAX Fund | USD 18.00 0.16 0.90% |
Slightly above 52% of Dreyfusthe Boston's investor base is interested to short. The analysis of overall sentiment of trading Dreyfusthe Boston Pany mutual fund suggests that many investors are impartial at this time. Dreyfusthe Boston's investing sentiment can be driven by a variety of factors including economic data, Dreyfusthe Boston's earnings reports, geopolitical events, and overall market trends.
Dreyfusthe |
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories Zacks Investment Research
Read at news.google.com
 |
Dreyfusthe Boston Fundamental Analysis
We analyze Dreyfusthe Boston's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfusthe Boston using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfusthe Boston based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
Dreyfusthe Boston is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
Dreyfusthe Boston Pany Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfusthe Boston mutual fund to make a market-neutral strategy. Peer analysis of Dreyfusthe Boston could also be used in its relative valuation, which is a method of valuing Dreyfusthe Boston by comparing valuation metrics with similar companies.
Peers
Dreyfusthe Boston Related Equities
| DIBAX | Dreyfus International | 0.58 | ||||
| DIBCX | Dreyfus International | 0.53 | ||||
| DHYCX | Dreyfus High | 0.46 | ||||
| DIEAX | Dreyfus International | 0.46 | ||||
| DHMBX | Dreyfus High | 0.37 | ||||
| DHYAX | Dreyfus High | 0.37 | ||||
| DZNJX | Dreyfus New | 0.34 | ||||
| DHGAX | Dreyfusstandish Global | 0.15 | ||||
| DHGCX | Dreyfusstandish Global | 0.15 | ||||
| DIECX | Dreyfus International | 0.03 |
Other Information on Investing in Dreyfusthe Mutual Fund
Dreyfusthe Boston financial ratios help investors to determine whether Dreyfusthe Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfusthe with respect to the benefits of owning Dreyfusthe Boston security.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |